DIFFERENTIAL FETAL DEVELOPMENT OF THE O-DEMETHYLATION AND N-DEMETHYLATION OF CODEINE AND DEXTROMETHORPHAN IN MAN

被引:70
作者
LADONA, MG [1 ]
LINDSTROM, B [1 ]
THYR, C [1 ]
PENG, DR [1 ]
RANE, A [1 ]
机构
[1] ACAD HOSP UPPSALA,DIV CLIN PHARMACOL,S-75185 UPPSALA,SWEDEN
关键词
CYTOCHROME P450 IID6 AND IIIA; DEXTROMETHORPHAN; CODEINE; HUMAN FETAL LIVER;
D O I
10.1111/j.1365-2125.1991.tb03902.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Codeine and dextromethorphan were N-demethylated in human foetal liver microsomes at high rates which were close to the activities in adult livers. In contrast, foetal liver microsomes did not catalyze the O-demethylation of these drugs at mid-gestation. 2 The metabolic data were in accordance with the absence of P450IID6 and the presence of P450 IIIA as determined by Western blotting with anti-human P450 IID6 (MAb 114/2) and anti-rat P450 IIIA (PCN 2-13-1/C2) monoclonal antibodies, respectively. 3 The inhibitory effects of midazolam and dehydroepiandrosterone support the contention that the N-demethylase is a human foetal form of the cytochrome P450 IIIA family. Consistent with this we found that blotting with the MAb PCN 2-13-1/C2, which recognizes an epitope specific for the P450 III family, correlated well with the N-demethylase activities.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 37 条
[1]   CLINICAL-SIGNIFICANCE OF THE SPARTEINE-DEBRISOQUINE OXIDATION POLYMORPHISM [J].
BROSEN, K ;
GRAM, LF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) :537-547
[2]  
CHEN ZR, 1988, LANCET, V2, P914
[3]   EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER [J].
DAVIES, DS ;
KAHN, GC ;
MURRAY, S ;
BRODIE, MJ ;
BOOBIS, AR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) :89-91
[4]   ENZYMATIC BASIS OF THE DEBRISOQUINE SPARTEINE-TYPE GENETIC-POLYMORPHISM OF DRUG OXIDATION - CHARACTERIZATION OF BUFURALOL 1'-HYDROXYLATION IN LIVER-MICROSOMES OF INVIVO PHENOTYPED CARRIERS OF THE GENETIC DEFICIENCY [J].
DAYER, P ;
KRONBACH, T ;
EICHELBAUM, M ;
MEYER, UA .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (23) :4145-4152
[5]   BIOACTIVATION OF THE NARCOTIC DRUG CODEINE IN HUMAN-LIVER IS MEDIATED BY THE POLYMORPHIC MONOOXYGENASE CATALYZING DEBRISOQUINE 4-HYDROXYLATION (CYTOCHROME-P-450 DBL/BUFI) [J].
DAYER, P ;
DESMEULES, J ;
LEEMANN, T ;
STRIBERNI, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 152 (01) :411-416
[6]   INTER-ETHNIC DIFFERENCE IN SPARTEINE OXIDATION AMONG GHANAIANS AND GERMANS [J].
EICHELBAUM, M ;
WOOLHOUSE, NM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (01) :79-83
[7]  
EICHELBAUM M, 1984, FED PROC, V43, P98
[8]   CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].
GONZALEZ, FJ ;
SKODA, RC ;
KIMURA, S ;
UMENO, M ;
ZANGER, UM ;
NEBERT, DW ;
GELBOIN, HV ;
HARDWICK, JP ;
MEYER, UA .
NATURE, 1988, 331 (6155) :442-446
[9]  
GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243
[10]  
GUENGERICH FP, 1986, MOL PHARMACOL, V30, P287